• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.

作者信息

Kishi Chikako, Motegi Sei-Ichiro, Yasuda Masahito, Ishikawa Osamu

机构信息

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.

出版信息

J Dermatol. 2018 Aug;45(8):1020-1022. doi: 10.1111/1346-8138.14512.

DOI:10.1111/1346-8138.14512
PMID:30133802
Abstract
摘要

相似文献

1
Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.羟氯喹给药对日本系统性/皮肤型红斑狼疮患者的治疗效果及不良事件
J Dermatol. 2018 Aug;45(8):1020-1022. doi: 10.1111/1346-8138.14512.
2
Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.羟氯喹对一名日本系统性红斑狼疮患者皮肤血管炎的有益作用。
J Dermatol. 2017 Apr;44(4):e52-e53. doi: 10.1111/1346-8138.13560. Epub 2016 Aug 29.
3
Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.米帕林与羟氯喹联合治疗系统性红斑狼疮伴难治性皮肤和关节活动患者。
Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.
4
Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.羟氯喹治疗红斑狼疮的经验。
J Dermatol. 2013 Feb;40(2):94-7. doi: 10.1111/1346-8138.12005. Epub 2012 Dec 6.
5
[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 10. Hydroxychloroquine].[风湿性疾病的治疗：现状与未来展望。主题：二、免疫抑制剂/抗风湿药物；10. 羟氯喹]
Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2960-5. doi: 10.2169/naika.100.2960.
6
Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.红斑狼疮患者口服羟氯喹后早期皮肤疹：病例报告及文献复习。
J Dermatol. 2018 Mar;45(3):344-348. doi: 10.1111/1346-8138.14156. Epub 2017 Dec 14.
7
Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.羟氯喹调节系统性红斑狼疮中 S100 蛋白的异常表达。
Lupus. 2019 Jun;28(7):826-833. doi: 10.1177/0961203319846391. Epub 2019 May 8.
8
Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.羟氯喹在日本皮肤型或系统性红斑狼疮患者中的群体药代动力学
Ther Drug Monit. 2016 Apr;38(2):259-67. doi: 10.1097/FTD.0000000000000261.
9
Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.皮肤型红斑狼疮和皮肌炎中抗疟药引起的药物性皮肤不良反应：一项回顾性队列研究。
J Am Acad Dermatol. 2019 Sep;81(3):859-860. doi: 10.1016/j.jaad.2019.04.068. Epub 2019 May 11.
10
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.用喹吖因和羟氯喹治疗狼疮皮肤受累。
Lupus. 2009 Jul;18(8):735-9. doi: 10.1177/0961203308101714.

引用本文的文献

1
Safety of Hydroxychloroquine: What a Dermatologist Should Know.羟氯喹的安全性：皮肤科医生应了解的内容。
Am J Clin Dermatol. 2025 Mar;26(2):251-264. doi: 10.1007/s40257-025-00919-x. Epub 2025 Feb 3.
2
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.新型冠状病毒肺炎患者与非新型冠状病毒肺炎患者短期口服氯喹和羟氯喹治疗的安全性：一项系统评价
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
3
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
羟氯喹在 COVID-19 和其他疾病中的安全性：53 项随机试验的系统评价和荟萃分析。
Eur J Clin Pharmacol. 2021 Jan;77(1):13-24. doi: 10.1007/s00228-020-02962-5. Epub 2020 Aug 11.
4
Cutaneous Lupus Erythematosus: Progress and Challenges.皮肤红斑狼疮：进展与挑战。
Curr Allergy Asthma Rep. 2020 Apr 4;20(5):12. doi: 10.1007/s11882-020-00906-8.
5
Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients.间充质干细胞：同种异体间充质干细胞可能具有免疫抑制作用，但自体间充质干细胞在狼疮患者中功能失调。
Front Cell Dev Biol. 2019 Nov 15;7:285. doi: 10.3389/fcell.2019.00285. eCollection 2019.